课题基金 / 基金详情

项目摘要

项目成果

BETTY P TSAO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):类风湿性关节炎(RA)是一种以关节慢性炎症为特征的全身性自身免疫性疾病,可能导致软骨和骨骼的结构性损害。核因子B受体激活剂配体(RANKL)在炎症性关节疾病中起关键作用。RANKL在骨破坏和免疫反应中的作用使其成为未来RA治疗的重要靶点。我们的初步数据显示,在类风湿因子阳性(RF+)高加索类风湿关节炎患者中,RANKL基因多态与发病年龄较早相关。这种关联在RF+非裔美国人RA患者中得到证实。在发生RA的第三个十年中,携带2个RANKL风险单倍型拷贝的RF+非裔美国患者的比例最高(33%),而在第四个十年(20%)、第五个(6%)、第六个(9%)和以后的十年(0%)发生RA的患者中呈下降趋势(p=0.004,与年龄相关的下降趋势)。这种RA发病年龄比例的下降趋势在抗CCP+非裔美国人患者(p=0.0006)和RF+高加索患者(p=0.03)中也很明显。RANKL风险单倍型在正常高加索人(10%)、RF+高加索RA患者(17%)和RF+多关节幼年特发性关节炎高加索患者(26%)中显著增加(p=0.002)。我们的结果显示,在两个不同的种族中,新的RANKL基因多态与RA发病的较早年龄显著相关。这些结果也提示了早发性和晚发性类风湿关节炎患者之间的遗传差异。我们建议1)精细定位RANKL基因,以确定与高加索人和非裔美国人RF+RA患者发病年龄较小相关的单倍型阻断(S)的边界,2)评估RA相关单倍型阻断(S)内潜在的功能多态,以定位RANKL因果变异(S)。这项研究的结果可能确定谁是早期RA风险最高的生物标记物,并可能为导致早期RA发展的分子机制提供新的见解,这可能对未来的治疗干预具有指导意义。本研究旨在识别基因多态,并了解易患类风湿关节炎(RA)早期发展的潜在分子机制。这项研究的结果可能会为确定年轻时RA的高危人群提供信息,这可能允许早期治疗干预以防止骨侵蚀。了解类风湿关节炎发病的分子机制可能会导致新的靶向药物的开发。
英文摘要
DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints, which may lead to structural damage of the cartilage and bone. The receptor activator of nuclear factor B ligand (RANKL) has been shown to play a pivotal role in inflammatory joint diseases. Its functions in bone destruction and immune responses make RANKL an important target for future RA therapies. Our preliminary data showed that RANKL genetic polymorphisms were associated with younger age of the disease onset in rheumatoid factor positive (RF+) Caucasian RA patients. This association was confirmed in RF+ African-American RA patients. The proportion of RF+ African-American patients carrying 2 copies of the RANKL risk haplotype was highest (33%) in those who developed RA during the third decade, with a declining trend among those who developed RA during their fourth (20%), fifth (6%), sixth (9%), and later (0%) decades (p = 0.004 for the age-related declining trend). This declining trend of proportion in age of RA onset was also evident in anti-CCP+ African- American patients (p = 0.0006) and RF+ Caucasian patients (p = 0.03). A significantly increasing trend of the RANKL risk haplotype was observed in normal Caucasian controls (10%), RF+ Caucasian RA patients (17%), and RF+ polyarticular juvenile idiopathic arthritis (JIA) Caucasian patients (26%) (p = 0.002). Our results showed significant association of novel RANKL polymorphisms with an earlier age at RA onset in two distinct ethnic groups. These results also suggested genetic differences between patients with early-onset and those with late-onset RA. We propose to 1) fine-map the RANKL gene to identify boundaries of haplotype block(s) associated with younger age of RA onset in both Caucasian and African-American RF+ RA patients, 2) assess potential functional polymorphisms within RA-associated haplotype block(s) to localize RANKL causal variant(s). Results from this study may identify biomarkers for who is at greatest risk for early RA and may shed new insights of molecular mechanisms leading to early development of RA, which may have implications for therapeutic interventions in the future. This study aims to identify genetic polymorphisms and to understand potential molecular mechanisms that predispose to early development of rheumatoid arthritis (RA). Results from this study are likely to provide information on the identification of individuals at high risk for RA at young ages, which may allow early therapeutic interventions to prevent bone erosions. The understanding of molecular mechanisms for the pathogenesis of RA may lead to the development of novel targeted medications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
Pathogenic role of SAT1 variants in monogenic lupus
Association of Androgen Receptor Polymorphisms with Damage in SLE
Association of Androgen Receptor Polymorphisms with Damage in SLE
海外基金